NUVVE HOLDING CORP (NVVE)

US67079Y2090 - Common Stock

0.6967  +0.02 (+2.38%)

After market: 0.6968 +0 (+0.01%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NVVE. NVVE was compared to 86 industry peers in the Electrical Equipment industry. Both the profitability and financial health of NVVE have multiple concerns. NVVE is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

In the past year NVVE has reported negative net income.
In the past year NVVE has reported a negative cash flow from operations.
In the past 5 years NVVE always reported negative net income.
In the past 5 years NVVE always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of NVVE (-153.78%) is worse than 92.86% of its industry peers.
With a Return On Equity value of -271.10%, NVVE is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -153.78%
ROE -271.1%
ROIC N/A
ROA(3y)-117.32%
ROA(5y)-98.29%
ROE(3y)-191.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 16.18%, NVVE is not doing good in the industry: 63.10% of the companies in the same industry are doing better.
NVVE's Gross Margin has declined in the last couple of years.
NVVE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.02%
GM growth 5Y-29.68%

2

2. Health

2.1 Basic Checks

NVVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NVVE has less shares outstanding
The number of shares outstanding for NVVE has been reduced compared to 5 years ago.
NVVE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -14.01, we must say that NVVE is in the distress zone and has some risk of bankruptcy.
NVVE has a Altman-Z score of -14.01. This is amonst the worse of the industry: NVVE underperforms 90.48% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NVVE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, NVVE is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.01
ROIC/WACCN/A
WACC10.62%

2.3 Liquidity

A Current Ratio of 1.57 indicates that NVVE should not have too much problems paying its short term obligations.
The Current ratio of NVVE (1.57) is worse than 63.10% of its industry peers.
NVVE has a Quick Ratio of 1.57. This is a bad value and indicates that NVVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NVVE (0.86) is worse than 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.86

7

3. Growth

3.1 Past

The earnings per share for NVVE have decreased strongly by -31629.41% in the last year.
NVVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.02%.
NVVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.87% yearly.
EPS 1Y (TTM)-31629.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-114048.48%
Revenue 1Y (TTM)55.02%
Revenue growth 3Y25.55%
Revenue growth 5Y42.87%
Revenue growth Q2Q43.02%

3.2 Future

NVVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.33% yearly.
NVVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 140.38% yearly.
EPS Next Y61.76%
EPS Next 2Y39.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year175.91%
Revenue Next 2Y140.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

NVVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NVVE's earnings are expected to grow with 39.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NVVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUVVE HOLDING CORP

NASDAQ:NVVE (5/10/2024, 7:10:08 PM)

After market: 0.6968 +0 (+0.01%)

0.6967

+0.02 (+2.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -153.78%
ROE -271.1%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.57
Quick Ratio 0.86
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-31629.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y61.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)55.02%
Revenue growth 3Y25.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y